Document is current
Any future updates will be listed below
-
Authors
Müller, Anne
Dunkl, Veronika
Müller, Wiebke
Hellmich, Martin
Löcherbach, Peter
Voltz, Raymond
Dillen, Kim
Goereci, Yasemin
Warnke, Clemens
Golla, Heidrun
,
Müller, Dirk
Civello, Daniele
Hobus, Dorthe
Bonmann, Eckhard
Schwartzkopff, Franziska
Nelles, Gereon
Palmbach, Gundula
Temmes, Herbert
Franke, Isabel
Haas, Judith
Strupp, Julia
Gerbershagen, Kathrin
Peters, Laura Becker
Burghaus, Lothar
Hagedorn, Carola
Hellmich, Martin
Müller, Wiebke
Paus, Martin
Ungeheuer, Solveig
Kochs, Sophia
Stock, Stephanie
Joist, Thomas
Limmroth, Volker
Pröh, Jule
Klein, Julia
Krüger, Merle
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 23 October 2024
Accepted: 5 February 2026
First Online: 14 March 2026
Declarations
:
: Ethical approval was obtained from the Ethics Committee of the University of Cologne (#20-1436) and is conducted under the Declaration of Helsinki. Participants were provided with oral and written information about the study and provided written informed consent.
: Not applicable.
: The study protocol is published [ ].
: Clemens Warnke has received institutional support from Novartis, Alexion, Sanofi Genzyme, Janssen, Biogen, Merck and Roche. The other authors declare that they have no competing interests.
